Thompson Siegel & Walmsley Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$72.2M |
| 2 |
Occidental Petroleum
OXY
|
+$47M |
| 3 |
Ryan Specialty Holdings
RYAN
|
+$39.9M |
| 4 |
CoStar Group
CSGP
|
+$38.8M |
| 5 |
Charter Communications
CHTR
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TD Synnex
SNX
|
+$57.5M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$50.1M |
| 3 |
Centene
CNC
|
+$46.6M |
| 4 |
Molina Healthcare
MOH
|
+$44.8M |
| 5 |
Linde
LIN
|
+$41.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.98% |
| 3 | Consumer Discretionary | 9.78% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 9.33% |
Similar funds
Thompson Siegel & Walmsley's Q2 2026 Portfolio in Review
As of Q2 2026, Thompson Siegel & Walmsley held 462 positions worth $5.57B, down 2.3% from $5.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Thompson Siegel & Walmsley withdrew a net $380M in Q2 2026, closing 27 positions and reducing 232 holdings. Its most notable exit was Best Buy, an estimated $7.42M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Thompson Siegel & Walmsley opened a new position in Zoetis worth $55.1M.
- Thompson Siegel & Walmsley's largest Q2 2026 buy was Zoetis: 766,798 shares worth $55.1M.
- Thompson Siegel & Walmsley added most to Occidental Petroleum in Q2 2026, an estimated $47M increase.
- Thompson Siegel & Walmsley's biggest Q2 2026 reduction was TD Synnex, cutting an estimated $57.5M.
- Thompson Siegel & Walmsley fully exited Best Buy in Q2 2026, selling an estimated $7.42M.
- Thompson Siegel & Walmsley's ten largest holdings make up 15% of its $5.57B portfolio in Q2 2026.
- Thompson Siegel & Walmsley opened 44 new positions and closed 27 in Q2 2026.
- Thompson Siegel & Walmsley's portfolio value fell 2.3% quarter-over-quarter to $5.57B.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.